Should You Buy Compass Pathways PLC (CMPS) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
CMPS is not a good buy right now for a Beginner long-term investor with $50k–$100k, based on the current downtrend setup and lack of Intellectia buy signals. While Wall Street price targets imply large upside and hedge funds have been adding, the stock is still technically weak (bearish momentum) and the business remains loss-making with no revenue. If you want long-term exposure to the psychedelic-therapy theme, CMPS is a reasonable watchlist name, but at this moment the data supports a HOLD (do not initiate a fresh position today).
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Technical Analysis
Price/Trend: CMPS is trading at $6.82 (-2.86% regular session), sitting below the pivot (7.149), which keeps the near-term bias bearish.
Momentum: MACD histogram is negative (-0.0987) and expanding downward, indicating selling pressure is strengthening rather than stabilizing.
RSI: RSI(6) at 33.59 is near oversold but not showing a confirmed reversal signal; this often precedes bounces, but it is not a buy trigger by itself.
Moving averages: Converging moving averages suggest the stock is in a compression phase after weakness; typically you want to see a breakout reclaiming the pivot to confirm trend improvement.
Key levels: Support S1=6.689 (very close to current price) then S2=6.404. Resistance starts at pivot 7.149 then R1=7.609. A clean reclaim and hold above ~7.15 would improve the technical picture; failing S1 increases downside risk toward ~6.40.
Analyst Ratings and Price Target Trends
Recent trend: Ratings and targets have moved more positive recently. Oppenheimer upgraded CMPS to Outperform (from Perform) with a $15 target on 2025-12-09, and RBC reiterated Outperform while raising its target to $21 from $16 on 2026-01-23.
Wall Street pros: High implied upside from current price, growing conviction around COMP360’s potential, and supportive institutional/hedge fund activity.
Wall Street cons: The stock remains highly speculative (pre-revenue, significant losses), and near-term price action is not confirming the bullish long-term narrative yet.
Influential/political trading: No recent congress trading data available; no politician/influential figure activity was provided.
Wall Street analysts forecast CMPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CMPS is 17.67 USD with a low forecast of 8 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast CMPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CMPS is 17.67 USD with a low forecast of 8 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 6.710
Current: 6.710
